Curtin University
Clinical trials sponsored by Curtin University, explained in plain language.
-
New hope for children with relapsing malaria: tafenoquine trial launches in PNG
Disease control Not yet recruitingThis study tests a single-dose drug called tafenoquine in 60 children with uncomplicated vivax malaria in Papua New Guinea. The goal is to see if it safely eliminates both blood-stage parasites and hidden liver-stage parasites that cause relapses. Researchers will measure how the…
Phase: PHASE4 • Sponsor: Curtin University • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
New study could lift ban on lifesaving malaria drugs for breastfeeding moms
Disease control Not yet recruitingThis study looks at whether the malaria drugs primaquine and tafenoquine are safe for breastfeeding mothers and their babies. Currently, these drugs are not recommended for the first six months after birth due to lack of safety data. The study will give the drugs to mothers right…
Phase: PHASE2, PHASE3 • Sponsor: Curtin University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Cheap aspirin could slash liver cancer risk in cirrhosis patients
Prevention Not yet recruitingThis study tests whether taking a low-dose aspirin (100 mg) every day can prevent liver cancer in people with cirrhosis, a condition that raises cancer risk. About 890 adults from Australian hospitals will take either aspirin or a dummy pill for 4 years while continuing their usu…
Phase: PHASE3 • Sponsor: Curtin University • Aim: Prevention
Last updated May 17, 2026 10:26 UTC